Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of Clinical Gastroenterology|May 25, 2006
Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis CAnna Maria Tommasi, Paolo Fabris, Isabella Carderi, et al.Journal of Medical Virology|January 15, 2003
Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virusPaolo Fabris, Giulia Tositti, Maria Teresa Giordani, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 14, 2004
Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis CPaolo Fabris, Dave Brown, Giulia Tositti, et al.European Journal of Gastroenterology & Hepatology|June 8, 2013
Therapy of chronic hepatitis C with PEG-IFN α-2b plus ribavirin in patients with genotype 2 or 3: 16 versus 24 weeks, clinical outcome and direct cost analysesPaolo Fabris, Antonio Carlotto, Tiziana Del Bianco, et al.Hepatology (Baltimore, Md.)|January 21, 2014
Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirinTeresa Santantonio, Massimo Fasano, Evangelista Sagnelli, et al.Journal of Hepatology|October 7, 2004
Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis CPaolo Fabris, Annarosa Floreani, Antonio Carlotto, et al.Current HIV Research|March 14, 2008
Impact of occult HBV infection in HIV/HCV co-infected patients: HBV-DNA detection in liver specimens and in serum samplesPaolo Fabris, Maria R Biasin, Maria T Giordani, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|November 20, 2010
Snail1 transcription factor is a critical mediator of hepatic stellate cell activation following hepatic injuryMelania Scarpa, Alessia R Grillo, Paola Brun, et al.Antimicrobial Agents and Chemotherapy|January 28, 2005
Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjectsMario Regazzi, Renato Maserati, Paola Villani, et al.Journal of Virology|September 11, 2009
Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infectionIsla Humphreys, Vicki Fleming, Paolo Fabris, et al.Pageof 3